Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05904847
Other study ID # 13353
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 16, 2023
Est. completion date October 26, 2023

Study information

Verified date May 2024
Source Sakarya University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is essential to manage the disease to prevent and reduce complications and mortality in patients with diabetes. Adequate information and options should be provided to patients by healthcare providers so that patients can make informed choices. Patient education is a patient empowerment process designed to enable patients to be responsible for their health. With this study, it is considered essential to educate diabetic patients according to the theory of planned behavior and to develop self-efficacy by contributing to patient empowerment in this way.


Recruitment information / eligibility

Status Completed
Enrollment 98
Est. completion date October 26, 2023
Est. primary completion date June 17, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Volunteering to participate in the study - 40 years and older - Diagnosed with type 2 DM at least 1 year ago - Treated at the hospital where the study will be conducted - Using antidiabetic agents - No communication problem - Contactable by phone Exclusion Criteria: - Those who do not meet the inclusion criteria for the study - Participants who did not give consent at any stage of the study and left

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Application of The Theory of Planned Behaviour for Diabetes
In the study, diabetes education consisting of a total of 4 sessions structured according to the Planned Behavior Theory will be applied to the intervention group, and a standard diabetes education consisting of a single session containing information about diabetes on the website of the Ministry of Health will be applied to the control group. The training will be given face-to-face in groups of 10-15 people. After the training, the participants will be monitored for 3 months. To increase patient empowerment and self-efficacy, the intervention group will be followed up by phone calls every 15 days to increase motivation and answer questions.

Locations

Country Name City State
Turkey Sakarya University Sakarya Serdivan

Sponsors (1)

Lead Sponsor Collaborator
Sakarya University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Empowerment Scale The scale consists of 37 items in total. Scale is graded in a 5-point Likert type, and in total, the lowest 37 and the highest 185 points are taken. There is an opposite item in the scale. This applied to individuals over the age of 18 who receive long-term care services. 2 weeks
Primary Diabetes Management Self-Efficacy Scale for Patients with Type 2 Diabetes The scale consists of 20 items in total. The scale is scored as a Likert type (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always), and the lowest score from the scale is 20 and the highest score is 100. 2 weeks
Secondary Blood Glucose Level A condition in which the blood glucose level is above normal. Hyperglycemia is mentioned when fasting blood glucose exceeds 100 mg/dl and postprandial blood glucose exceeds 140 mg/dl. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT05359341 - Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients? N/A
Recruiting NCT04700813 - Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
Completed NCT05413330 - Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. Phase 2/Phase 3
Recruiting NCT04927377 - Accessible and Inclusive Diabetes Telecoaching Self-Management Program N/A
Completed NCT05585268 - Electronic Decision Support for Deprescribing in Patients on Hemodialysis N/A
Active, not recruiting NCT05088616 - Native American Diabetes Project N/A
Not yet recruiting NCT03273738 - Vascular and Metabolic Changes in Postmenopausal Diabetics
Active, not recruiting NCT04642911 - Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
Withdrawn NCT04283617 - Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study N/A
Recruiting NCT04769687 - Symbiotics and Systemic Inflammation in Chronic Kidney Disease Phase 2
Withdrawn NCT06104358 - Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes Phase 2
Recruiting NCT03341793 - Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery N/A
Not yet recruiting NCT06080802 - The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction Phase 2/Phase 3
Recruiting NCT04485845 - Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression Phase 4
Recruiting NCT05050500 - The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction Phase 4
Completed NCT04115657 - The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study) N/A
Completed NCT06188572 - The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
Completed NCT04120844 - Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China N/A
Completed NCT05789706 - Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans N/A